Shanghai Fosun Pharma executes share buyback program

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced that it repurchased 532,800 of its ordinary shares on June 30, 2025, on the Shanghai Stock Exchange. The shares were bought back at prices ranging from RMB 25.05 to RMB 25.09, with an aggregate price paid of RMB 13,354,173. Following the repurchase, the total number of issued shares stands at 2,118,488,825, with 19,906,252 shares held as treasury shares. The company confirmed the repurchase was conducted in accordance with applicable domestic rules and regulations.